KGP-25
KGP-25 is an inhibitor of voltage-gated sodium channel 1.8 (Nav1.8), which can be used for analgesia by targeting Nav1.8 in the peripheral nervous system (PNS) . KGP-25 can also target γ-aminobutyric acid subtype A receptor (GABAA) in the central nervous system (CNS) for general anesthesia[1].
Product Specifications
UNSPSC
12352005
Target
GABA Receptor; Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/kgp-25.html
Purity
95.0
Smiles
CC(C1=C(C(C(C)C)=CC=C1)OC(OCC[NH+](CC)CC)=O)C.[Cl-]
Molecular Formula
C19H32ClNO3
Molecular Weight
357.92
References & Citations
[1]Huang T, ey al. Molecular Transformers: Adaptive Multitarget Ligands for Esterase-Induced Transition from Analgesics to Anesthetics. J Med Chem. 2024 Jul 25;67 (14) :12349-12365.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15398840 1 Vial
Lentiviral human TRMT44 sgRNA gene knockout kit - Lentiviral human TRMT44 sgRNA gene knockout kit (plasmid)
Ask
View Details MBS1484186-01 0.02 mg (E-Coli)
Recombinant Dictyostelium discoideum Putative uncharacterized protein DDB_G0275531 (DDB_G0275531)
Ask
View Details